(please share) Immediate #postdoc job opening in the Millman lab at WashU Med (St. Louis, MO).
Want to develop next-generation pancreatic islets for the study and treatment of diabetes? Email your CV to apply
sites.wustl.edu/millmanlab/
Posts by
Using advanced microscopy and multi-omics approaches, we identify histone methyltransferase EZH2, along with key chromatin remodelers, as central regulators of MSC phenotypic drift during expansion.
New preprint from our lab! We investigated how MSCs lose potency during serial passaging - a critical bottleneck in MSC manufacturing, and how epigenetic interventions can help preserve their quality at the therapeutic endpoint. www.biorxiv.org/content/10.6...
Turns out, epigenetic regulation plays a central role in how cells respond to oxidative stress having implications for regenerative medicine and aging research.
Have a look! Executed by a team of PhD, MS and undergraduate students in our lab.#stemcells #epigenetics #chromatin #regenerativemedicine
What we found: ROS triggers striking chromatin compaction and remodeling — but pretreatment with a selective EZH2 inhibitor (GSK126) alters this response, preserving chromatin accessibility and reducing DNA damage.
This can occur at critical moments — like after therapeutic expansion and delivery to injury sites, or during inflammation in native tissues. To explore this, we combined high-resolution live-cell imaging with ATAC-seq to track real-time changes in chromatin architecture.
This is my first Bluesky post to a very limited connection. New paper published from our lab and it is open access! What happens to the chromatin structure of mesenchymal stem/stromal cells when they’re exposed to high levels of reactive oxygen species (ROS)?
doi.org/10.1002/adbi...